Effective inhibition of the epidermal growth factor/epidermal growth factor receptor binding by anti-epidermal growth factor antibodies is related to better survival in advanced non-small-cell lung cancer patients treated with the epidermal growth factor cancer vaccine

Article

Abstract: Purpose: Epidermal growth factor (EGF) might be a suitable immunotherapeutic target in non-small-cel

Palabras claves:

Autores:

Carmen Elena Viada, De La Torre A.V., García Verdecia B., González G., Lage Davila A., Leonard I., Martínez R., Mazorra Z., Neninger Vinageras E., Tania Crombet

Fuentes:

scopus